Health & Fitness
Health and Fitness
Health and Fitness
Mon, January 10, 2011
Sun, January 9, 2011
Fri, January 7, 2011
Teva to Present at the 29th Annual J.P. Morgan Healthcare Conference
JERUSALEM--([ BUSINESS WIRE ])--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the 29th Annual J.P. Morgan Healthcare Conference with Eyal Desheh, CFO, Teva Pharmaceutical Industries Ltd. and William Marth, President & CEO, Teva Pharmaceuticals - Americas, presenting on Tuesday, January 11, 2011 in San Francisco.
What: | Teva Presentation at the 29th Annual J.P. Morgan Healthcare Conference | |
Who: | Eyal Desheh, CFO, Teva Pharmaceutical Industries and | |
| William Marth, President & CEO, Teva Pharmaceuticals a" Americas | ||
When: | Tuesday, January 11th, 2011, at 1:30 PM Pacific Standard Time | |
Where: | [ www.tevapharm.com/financial/ ] or | |
[ http://jpmorgan.metameetings.com/webcasts/healthcare11/directlink?ticker=TEVA ] | ||
How: | Live over the Internet a" log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will also be available on Teva's website. | |
About Teva
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,250 molecules and a direct presence in approximately 60 countries. Teva's branded businesses focus on neurological, respiratory and women's health therapeutic areas as well as biologics. Teva's leading innovative product, Copaxone®, is the number one prescribed treatment for multiple sclerosis. Teva employs more than 40,000 people around the world and reached $13.9 billion in net sales in 2009.
